Showing results (21-30 of 140) with videos related to
Sort By:
Pageof 14
Infection and Immunity|October 1, 1975
Nature of "memory" in T-cell-mediated antibacterial immunity: anamnestic production of mediator T cellsR J NorthThe Journal of Experimental Medicine|November 1, 1986
Radiation-induced, immunologically mediated regression of an established tumor as an example of successful therapeutic immunomanipulation. Preferential elimination of suppressor T cells allows sustained production of effector T cellsR J NorthThe Journal of Experimental Medicine|April 1, 1982
Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cellsR J NorthCancer Immunology, Immunotherapy : CII|January 1, 1984
Gamma-irradiation facilitates the expression of adoptive immunity against established tumors by eliminating suppressor T cellsR J NorthThe Journal of Experimental Medicine|September 1, 1970
Suppression of cell-mediated immunity to infection by an antimitotic drug. Further evidence that migrant macrophages express immunityR J NorthThe Journal of Experimental Medicine|August 1, 1973
Cellular mediators of anti-Listeria immunity as an enlarged population of short lived, replicating T cells. Kinetics of their productionR J NorthClinical and Experimental Immunology|August 11, 1998
Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosisR J NorthThe Journal of Experimental Medicine|December 1, 1971
The action of cortisone acetate on cell-mediated immunity to infection. Suppression of host cell proliferation and alteration of cellular composition of infective fociR J NorthCancer Immunology, Immunotherapy : CII|January 1, 1984
The therapeutic significance of concomitant antitumor immunity. I. LY-1-2+ T cells from mice with a progressive tumor can cause regression of an established tumor in gamma-irradiated recipientsR J NorthCancer Immunology, Immunotherapy : CII|January 1, 1984
The therapeutic significance of concomitant antitumor immunity. II. Passive transfer of concomitant immunity with Ly-1+2- T cells primes established tumors in T cell-deficient recipients for endotoxin-induced regressionR J NorthPageof 14